Jul. 16 at 12:56 PM
$CVRX GREAT NEWS.
Now it is certain that Barostim will get reimbursement from Medicare of AT LEAST
$45,000 per procedure AND there is a potential for even more if CME gives it a Level 6 APC.
"A Level 6 Neurostimulator Ambulatory Payment Classification (APC) is a payment group within the Medicare system for certain neurostimulator and related procedures performed in outpatient settings. It is a higher-cost category than the existing Level 5 Neurostimulator APC. The creation of a Level 6 APC aims to better reflect the costs associated with more complex neurostimulation procedures, particularly those involving new technologies.
Key Points:
Higher Costs:
Level 6 APCs are designed for procedures with higher resource utilization and costs compared to Level 5.
New Technologies:
The creation of a Level 6 APC is often driven by the introduction of new neurostimulation devices and techniques.
Medicare Reimbursement:
Medicare uses APCs to determine payment for outpatient services.
